Trends in survival of patients diagnosed with male genital cancers in the Nordic countries 1964–2003 followed up until the end of 2006

Figures & data

Table I. Trends in survival for prostate cancer by country. Number of tumours (N) included and the 5- and 10-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
S-year
1964–1968	3 631	31 (28–34)	2 013	41 (37–46)	105	40 (27–58)	4 547	46 (42–50)	12 301	44 (42–46)
1969–1973	4 254	36 (33–39)	2 981	44 (40–47)	144	39 (30–52)	5 211	51 (47–54)	14 966	48 (46–50)
1974–1978	5 312	36 (33–38)	3 841	54 (51–58)	216	62 (52–73)	6 709	51 (49–54)	16 069	56 (54–58)
1979–1983	6 379	42 (38–45)	5 028	54 (51–57)	327	55 (46–66)	7 669	53 (50–56)	18 208	56 (54–58)
1984–1988	6 824	39 (36–41)	5 983	55 (52–58)	420	64 (57–73)	8 626	53 (50–56)	21 766	60 (59–62)
1989–1993	7 318	38 (35–41)	7 804	60 (57–62)	524	69 (63–77)	10 371	58 (56–61)	25 113	65 (63–66)
1994–1998	7 616	42 (40–45)	13 164	73 (71–75)	709	76 (71–82)	12 817	71 (70–73)	29 116	72 (71–74)
1999–2003	10 471	53 (51–55)	18 291	86 (84–87)	868	81 (78–85)	14 903	78 (77–79)	39 292	81 (80–82)
10-year
1964–1968	3 631	18 (15–21)	2 013	28 (24–33)	105	12 (7–21)	4 547	29 (25–33)	12 301	29 (27–31)
1969–1973	4 254	19 (16–22)	2 981	27 (23–31)	144	21 (14–31)	5 211	33 (29–36)	14 966	32 (30–34)
1974–1978	5 312	19 (17–22)	3 841	36 (33–40)	216	47 (36–61)	6 709	35 (32–38)	16 069	39 (37–42)
1979–1983	6 379	23 (20–26)	5 028	38 (35–42)	327	42 (32–55)	7 669	36 (33–39)	18 208	38 (36–40)
1984–1988	6 824	22 (20–24)	5 983	37 (34–40)	420	46 (37–56)	8 626	36 (34–39)	21 766	42 (40–44)
1989–1993	7 318	20 (18–22)	7 804	43 (40–46)	524	57 (49–66)	10 371	40 (37–42)	25 113	45 (43–47)
1994–1998	7 616	22 (21–24)	13 164	58 (56–60)	709	63 (57–68)	12 817	52 (50–53)	29 116	53 (51–53)
1999–2003	10 471	29 (27–31)	18 291	73 (71–75)	868	68 (63–74)	14 903	58 (57–60)	39 292	60 (58–61)

Figure 1. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5- and 10-year relative survival for prostate cancer by country. Nordic cancer survival study 1964–2003.

Table II. Trends in 5- and 10-year age-specific relative survival in percent after prostate cancer by country. Nordic cancer survival study 1964–2003.

Age	5-year survival						10-year survival
	0–49	50–59	60–69	70–79	80–89	90 +	0–49	50–59	60–69	70–79	80–89	90 +
Denmark
1964–1968	19	31	41	33	16	0	20	17	22	16	11	0
1969–1973	45	40	40	35	21	30	22	24	22	18	6	77
1974–1978	21	42	41	37	27	7	13	25	23	20	9	0
1979–1983	54	46	44	40	25	13	32	28	25	21	9	0
1984–1988	22	40	44	42	35	28	9	19	27	26	17	0
1989–1993	27	31	42	43	37	32	6	17	24	23	23	0
1994–1998	36	38	48	43	39	18	15	20	26	24	20	0
1999–2003	39	58	61	54	44	29	28	31	32	28	22	0
Finland
1964–1968	56	48	45	38	19	0	52	36	30	24	4	0
1969–1973	28	40	52	49	35	28	22	29	34	27	15	0
1974–1978	52	54	59	55	46	21	30	38	43	33	34	0
1979–1983	42	50	62	59	42	42	30	35	45	44	27	0
1984–1988	27	52	61	64	52	18	20	39	42	42	29	57
1989–1993	38	54	65	66	60	38	36	37	49	48	34	0
1994–1998	47	80	82	76	65	58	36	64	67	60	49	56
1999–2003	75	90	91	87	77	68	57	78	80	75	64	66
Iceland
1964–1968	31	31	45	23	81	*	26	26	17	*	*	*
1969–1973	15	15	51	56	33	*	37	37	39	*	*	*
1974–1978	68	68	74	53	44	133	58	58	54	35	34	*
1979–1983	44	44	68	57	48	*	48	48	48	37	26	*
1984–1988	55	55	79	62	59	*	38	38	64	39	41	*
1989–1993	69	69	61	75	73	56	62	62	54	59	49	*
1994–1998	74	74	77	81	71	74	65	65	63	65	53	*
1999–2003	83	83	83	83	72	54	71	71	71	67	59	*
Norwtay
1964–1968	51	53	53	42	26	8	40	32	36	21	18	0
1969–1973	51	57	57	49	35	7	34	40	38	31	15	0
1974–1978	45	52	57	53	41	50	30	41	41	33	25	0
1979–1983	30	54	59	56	51	40	19	41	43	37	33	0
1984–1988	35	51	60	56	49	37	29	37	44	37	27	44
1989–1993	39	61	64	63	50	34	30	39	46	44	28	0
1994–1998	73	77	78	69	57	33	56	60	59	48	31	15
1999–2003	76	86	86	76	60	34	65	70	67	53	34	0
Sweden
1964–1968	44	47	50	42	31	6	35	34	34	26	16	0
1969–1973	55	54	54	46	31	17	39	38	37	28	17	0
1974–1978	54	62	60	55	42	27	38	45	43	39	29	0
1979–1983	32	61	63	59	52	45	21	41	45	39	34	22
1984–1988	42	62	65	64	58	51	25	46	47	44	39	0
1989–1993	49	63	69	68	63	48	36	47	51	47	37	28
1994–1998	62	78	79	73	62	65	39	60	59	52	41	27
1999–2003	78	88	87	79	70	74	52	72	67	57	44	36

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref. [15].

Figure 2. Trends in age-standardised (ICSS) excess death rates per 100 person years for prostate cancer by country and time since diagnosis in Nordic cancer survival study 1964–2003.

Figure 3. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for testis cancer by country. Nordic cancer survival study 1964–2003.

Table III. Trends in survival for testis cancer by country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
S-year
1964–1968	602	57 (52–62)	115	49 (40–60)	7	*	328	64 (56–73)	501	66 (61–71)
1969–1973	784	59 (55–64)	173	57 (48–67)	15	*	425	55 (50–59)	588	67 (61–72)
1974–1978	991	74 (69–79)	206	59 (53–66)	17	*	492	71 (64–78)	656	69 (65–74)
1979–1983	1 075	83 (79–88)	206	73 (65–83)	15	*	611	82 (76–88)	769	88 (83–93)
1984–1988	1 217	84 (80–89)	295	80 (74–87)	38	*	772	87 (83–92)	902	90 (86–94)
1989–1993	1 366	89 (85–93)	348	84 (78–90)	45	*	957	87 (83–92)	1 075	93 (88–97)
1994–1998	1 464	91 (87–96)	377	87 (79–96)	44	*	1 032	91 (86–97)	1 140	92 (88–96)
1999–2003	1 338	93 (89–97)	482	88 (83–94)	41	*	1 184	92 (88–97)	1 249	94 (90–97)

*Too few patients to calculate survival, see ref. [15].

Figure 4. Trends in age-standardised (ICSS) excess death rates per 100 person years for testis cancer by country and time since diagnosis in Nordic cancer survival study 1964–2003. No Icelandic curves. Too few partients to calculate survival in Iceland.

Table IV. Trends in 5-year age-specific relative survival in percent after testis cancer by country. Nordic cancer survival study 1964–2003.

Age	5-year survival
	0–29	30–39	40–49	50–69	70–89	90+
Denmark
1964–1968	50	69	69	70	27	*
1969–1973	53	74	75	69	25	*
1974–1978	73	86	83	75	49	*
1979–1983	88	94	93	80	53	*
1984–1988	93	94	91	83	46	*
1989–1993	93	96	94	92	63	*
1994–1998	96	97	97	87	75	*
1999–2003	98	97	98	88	77	*
Finland
1964–1968	43	71	59	51	17	*
1969–1973	48	81	66	53	38	*
1974–1978	59	78	80	72	0	*
1979–1983	80	84	66	77	46	*
1984–1988	89	88	98	81	34	*
1989–1993	94	95	99	91	26	*
1994–1998	94	95	96	90	48	*
1999–2003	95	97	96	85	60	*
Norway
1964–1968	57	73	76	67	48	*
1969–1973	52	66	83	69	0	*
1974–1978	71	79	82	78	42	*
1979–1983	94	91	95	85	28	*
1984–1988	96	97	92	86	54	*
1989–1993	96	97	96	99	32	*
1994–1998	96	99	93	93	65	*
1999–2003	97	98	95	92	71	*
Sweden
1964–1968	58	74	79	77	43	*
1969–1973	60	86	71	60	56	*
1974–1978	71	73	81	69	52	*
1979–1983	91	90	88	80	89	*
1984–1988	95	94	94	87	74	*
1989–1993	97	98	97	88	80	*
1994–1998	97	99	96	91	66	*
1999–2003	98	98	97	94	76	*

*Too few patients to calculate survival, see ref. [15]. Iceland not shown for same reason.

Figure 5. Trends in age-standardised (World) incidence and mortality rates per 100 000 and age-standardised (ICSS) 5-year relative survival for cancer of the penis and other male genital organs by country. Nordic cancer survival study 1964–2003.

Table V. Trends in survival for cancer of the penis and other male genital organs by country. Number of tumours (N) included and the 5-year age-standardised (ICSS) relative survival in percent with 95% confidence intervals (RS (CI)). Nordic cancer survival study 1964–2003.

	Denmark		Finland		Iceland		Norway		Sweden
	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)	N	RS (CI)
S-year
1964–1968	191	63 (54–73)	62	64 (53–79)	5	*	114	61 (50–74)	269	70 (62–79)
1969–1973	189	65 (56–76)	69	64 (53–79)	3	*	120	68 (56–83)	320	69 (61–77)
1974–1978	188	72 (64–83)	72	64 (49–83)	2	*	127	88 (77–100)	288	73 (66–81)
1979–1983	219	72 (63–81)	65	67 (53–84)	5	*	130	76 (65–89)	302	69 (62–76)
1984–1988	229	70 (62–79)	72	65 (50–86)	5	*	136	69 (58–80)	315	70 (63–78)
1989–1993	196	63 (55–72)	97	65 (52–83)	10	*	125	74 (64–86)	325	71 (64–78)
1994–1998	235	74 (66–83)	98	65 (54–79)	9	*	196	79 (71–88)	324	70 (63–77)
1999–2003	265	74 (67–81)	110	62 (51–74)	9	*	176	80 (73–88)	425	70 (65–75)

*Too few patients to calculate survival, see ref. [15].

Figure 6. Trends in age-standardised (ICSS) excess death rates per 100 person years for cancer of the penis and other male genital organs by country and time since diagnosis in Nordic cancer survival study 1964–2003. No Icelandic curves. Too few partients to calculate survival for Iceland.

Table VI. Trends in 5-year age-specific relative survival in percent after cancer of the penis and other male genital organs by country. Nordic cancer survival study 1964–2003.

Age	5-year survival
	0–49	50–59	60–69	70–79	80–89	90+
Denmark
1964–1968	71	71	70	61	35	*
1969–1973	86	70	58	64	60	*
1974–1978	83	81	67	70	69	*
1979–1983	83	92	74	59	58	*
1984–1988	82	72	66	75	57	0
1989–1993	71	73	57	79	25	0
1994–1998	88	75	66	72	80	*
1999–2003	73	75	74	73	75	59
Finland
1964–1968	73	74	68	73	23	*
1969–1973	73	74	68	73	23	*
1974–1978	72	64	59	98	0	*
1979–1983	68	82	76	83	0	*
1984–1988	72	68	54	75	60	*
1989–1993	79	26	66	78	73	*
1994–1998	81	58	91	60	24	*
1999–2003	76	64	82	49	34	*
Norway
1964–1968	71	66	76	47	46	*
1969–1973	43	70	77	67	73	*
1974–1978	93	85	89	76	106	*
1979–1983	91	73	75	74	72	0
1984–1988	74	78	84	55	52	*
1989–1993	83	84	74	53	98	*
1994–1998	83	88	87	71	67	*
1999–2003	80	86	78	87	66	99
Sweden
1964–1968	82	79	67	64	66	*
1969–1973	81	68	70	71	53	*
1974–1978	85	83	81	75	33	*
1979–1983	84	81	74	61	48	*
1984–1988	79	77	72	61	71	0
1989–1993	73	82	79	64	55	0
1994–1998	69	78	63	74	65	71
1999–2003	78	72	65	65	76	70

Numbers in italics indicate that two or more cells had to be combined to get sufficient number of patients to calculate survival.

*Too few patients to calculate survival, see ref [15]. Iceland not shown for same reason.

Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol.

 Google Scholar